Cited by 52Sesquiterpenes and Asteraceae StudiesNatural product bioactivities and synthesisPharmacological Effects of Medicinal Plants

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Sesquiterpenes α-humulene and β-caryophyllene oxide enhance the efficacy of 5-fluorouracil and oxaliplatin in colon cancer cells

Open access

Abstract

The present study is designed to find out if sesquiterpenes, α-humulene (HUM), valencene (VAL), β-caryphyllene-oxide (CAO) and trans-nerolidol (NER), are able to improve the antiproliferative effect of classical cytostatic drugs, 5-fluorouracil (FU) and oxaliplatin (1,2-diaminocyclohexaneoxalato-platinum, OxPt), in colon cancer cell lines Caco-2 and SW-620. In addition, the possible mechanisms of sesquiterpene action are studied. The results show significant ability of HUM and especially of CAO to enhance the anti-proliferative effects of FU and OxPt in cancer cell lines Caco-2 and SW-620. On the other hand, VAL and NER are ineffective. The action of CAO could be partly based on its ability to disrupt the mitochondrial membrane potential and to activate initiator caspases, but other mechanisms are probably also involved. Based on these results, CAO seems to have the potential for combination therapy of colon cancers and deserves further study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2478/acph-2019-0003

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

Sorted by citations

See all 52

Metadata

Authors
Ambrož, M., Šmatová, M., Šadibolová, M., Pospíšilová, E., Hadravská, P., Kašparová, M., Skarková, V. H., Králová, V., & Skálová, L.
Affiliations
Charles University (CZ)
Corresponding author
Skálová, Lenka
Venue
Acta Pharmaceutica
Published
2018-12-07
Volume
69
Issue
1
Pages
121-128
ISSN
  • 1330-0075 (ISSN-L)
  • 1846-9558
OpenAlex
W2905047533
Cited by
52
References
13
Citations by year
2026: 3 · 2025: 5 · 2024: 8 · 2023: 6 · 2022: 10 · 2021: 9 · 2020: 8 · 2019: 3
FWCI
1.51
Type
journal article
Language
en
Open access
Locations
  • Acta Pharmaceutica (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • University of Zagreb University Computing Centre (SRCE) (submittedVersion, other-oa)
Funders
  • Univerzita Karlova v Praze (SVV260416, P303/12/G163)
  • Grantová Agentura České Republiky (GBP303/12/G163)
Topics
  • Physical Sciences › Chemistry › Organic Chemistry › Sesquiterpenes and Asteraceae Studies
  • Physical Sciences › Chemistry › Organic Chemistry › Natural product bioactivities and synthesis
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacological Effects of Medicinal Plants
Keywords
sesquiterpenes, α-humulene, caryophyllene oxide, valencene, trans-nerolidol, 5-fluorouracil, oxaliplatin, colon cancer, combination chemotherapy, antiproliferative activity, mitochondrial membrane potential, caspase activation, Caco-2 cells, SW620 cells
MeSH terms
Oxaliplatin, Monocyclic Sesquiterpenes, Polycyclic Sesquiterpenes, Colonic Neoplasms, Fluorouracil, Humans, Sesquiterpenes, Caco-2 Cells, Cell Line, Tumor, Cell Proliferation, Membrane Potential, Mitochondrial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review